A detailed history of Fairview Capital Investment Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Fairview Capital Investment Management, LLC holds 16,070 shares of NVO stock, worth $1.69 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
16,070
Previous 16,070 -0.0%
Holding current value
$1.69 Million
Previous $2.29 Million 16.57%
% of portfolio
0.11%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $730,702 - $1.6 Million
8,035 Added 100.0%
16,070 $1.46 Million
Q2 2017

Aug 14, 2017

BUY
N/A
8,035
8,035 $345,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Fairview Capital Investment Management, LLC Portfolio

Follow Fairview Capital Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairview Capital Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairview Capital Investment Management, LLC with notifications on news.